Back

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

29 August 2020 (18:50 - 19:05)
Organised by:
Congress Presentation Part of: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients Treatment Open Access ESC Congress 2020

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor J. Butler (Dallas, US)
Video
Presentation thumbnail
EMPEROR-REDUCED Trial: main results.
Doctor M. Packer (Dallas, US)
Video
Presentation thumbnail
Panel discussion
Professor G. Filippatos (Athens, GR) Professor M. Packer (Dallas, US) Professor J. Butler (Dallas, US) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor S. Anker (Berlin, DE)
Video
Presentation thumbnail
Conclusion.
Professor M. Packer (Dallas, US)
Video

Access the full session

Session thumbnail
New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
Video

The Event

Event poster

ESC Congress 2020

29 August 2020 18:50 CET
You may be interested in
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources